ZURICH (Reuters) – Novartis’ Sandoz unit has agreed to pay $ 150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.
Recent Posts Categories Best Trends Business Financial Hot News Hot trends Info News